Techno Trends

Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.

European Commission Approves New Regulatory Framework for Digital Health Technologies

The European Commission has introduced a new regulatory framework aimed at streamlining the approval process for digital health technologies across member states....

Breakthrough in Gene Therapy Manufacturing in Europe: New Techniques Address Cost Challenges

Innovative manufacturing techniques for gene therapy in Europe are addressing key cost challenges faced by the industry....

European Biopharmaceuticals Sector Gears Up for Digital Transformation as Funding Increases

The biopharmaceuticals sector in Europe is witnessing a significant push towards digital transformation driven by increased funding....

New Regulations Proposed for Clinical Trials in Europe to Enhance Transparency

Proposed regulations aim to enhance transparency and data sharing in European clinical trials....

European Biopharma Companies Collaborate on mRNA Vaccine Development

Several European biopharma companies have announced a new collaboration aimed at advancing mRNA vaccine technology....

New Advanced Manufacturing Techniques Transform Biopharma Production Efficiency in Europe

New manufacturing technologies are set to enhance production efficiency in Europe's biopharma industry....

European Biopharma Leaders Forge New Collaborative Initiative for Innovative Drug Development

European biopharma leaders announced a new initiative aimed at accelerating innovative drug development through enhanced collaboration....

FDA Grants Breakthrough Therapy Designation to Izalontamab Brengitecan for Lung Cancer

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to izalontamab brengitecan (Iza-bren), an investigational treatment for adults with advanced non-small cell lung cancer (NSCLC). ...

Porosome Therapeutics Announces Breakthrough Discoveries in Alzheimer’s Research

Porosome Therapeutics, Inc. had announced major progress in the fight against Alzheimer’s Disease (AD) with a first-of-its-kind therapeutic platform that addresses the root causes of the condition, rather than just managing symptoms....

AstraZeneca’s IMFINZI® Receives Breakthrough Therapy for Early Gastric and Gastroesophageal Cancers

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s regulatory filing for IMFINZI® (durvalumab) to treat patients with resectable, early-stage gastric and gastroesophageal junction (GEJ) cancers. ...